Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

November 30, 2004

Conditions
Cardiovascular DiseaseCoronary Artery Bypass Surgery
Interventions
DRUG

Heparin

Unfractionated Heparin per institutional practice

DRUG

Bivalirudin

1.0 mg/kg IV bolus followed by a 2.5 mg/kg/hr IV infusion

Trial Locations (1)

44195

The Cleveland Clinic, Cleveland

Sponsors
All Listed Sponsors
lead

The Medicines Company

INDUSTRY